In the News
Nurofen - product differentiation or price discrimination?

14th December 2015
The Australian judiciary has told the makers of Nurofen (Reckitt Benckiser) that they must withdraw their range of products from Australian shelves, because the products all contain identical ingredients but are packaged, branded, and priced differently. For example, Nurofen products targeted at migraine relief contain exactly the same active ingredient as normal Nurofen, but is more expensive.
You might also like

Collusion in Oligopoly - Ten construction firms fined total £60m
26th March 2023

Price Discrimination and Economic Welfare
29th November 2022
Price Discrimination and Consumer Welfare - A-Level Economics Essay Walkthrough
Practice Exam Questions

Penguin Scraps Merger Plan with Rival Publisher
22nd November 2022

Competition Policy - Mega Publishing Merger is Blocked
1st November 2022